Suntrust Banks’s GW Pharmaceuticals Plc American Depositary Shares GWPH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q3
$1.3M Sell
11,266
-415
-4% -$63K 0.01% 690
2019
Q2
$2.01M Buy
11,681
+155
+1% +$26.8K 0.01% 589
2019
Q1
$1.94M Buy
11,526
+4,339
+60% +$646K 0.01% 579
2018
Q4
$700K Sell
7,187
-7,809
-52% -$1.02M ﹤0.01% 795
2018
Q3
$2.59M Sell
14,996
-2,092
-12% -$302K 0.01% 481
2018
Q2
$2.38M Buy
17,088
+15,067
+746% +$2.14M 0.01% 494
2018
Q1
$228K Buy
+2,021
New +$254K ﹤0.01% 1153

Other funds holding GWPH

Suntrust Banks's GWPH Position: Q3 2019 in Review

Suntrust Banks reduced its GW Pharmaceuticals Plc American Depositary Shares (GWPH) stake by 3.6% in Q3 2019, selling an estimated $63K and leaving 11,266 shares worth $1.3M. The position accounts for 0.01% of the portfolio, ranked #690.

Suntrust Banks first reported a position in GWPH in Q1 2018 and has held it in 7 quarters since. The position peaked at $2.59M in Q3 2018. 316 funds tracked by Wall St. Rank hold GWPH as of Q3 2019.

  • Suntrust Banks held 11,266 shares of GW Pharmaceuticals Plc American Depositary Shares worth $1.3M as of Q3 2019.
  • Suntrust Banks sold 415 GW Pharmaceuticals Plc American Depositary Shares shares in Q3 2019, an estimated $63K.
  • GW Pharmaceuticals Plc American Depositary Shares made up 0.01% of Suntrust Banks's portfolio in Q3 2019, its #690 holding.
  • Suntrust Banks first reported a position in GW Pharmaceuticals Plc American Depositary Shares in Q1 2018 and has held it in 7 quarters since.
  • Suntrust Banks's GW Pharmaceuticals Plc American Depositary Shares position peaked at $2.59M in Q3 2018.
  • 316 funds tracked by Wall St. Rank held GW Pharmaceuticals Plc American Depositary Shares as of Q3 2019.

Based on Suntrust Banks's 13F filing for Q3 2019, filed 12 Nov 2019.